drugset / Trial / NCT03112187

FLIPS: Ferfer Liposomal Iron Performance Study

NCT03112187 ↗

Phase 4 Completed 400 enrolled PharmEvo Pvt Ltd
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy of a novel food supplement, Ferfer® to raise the capacity of Haemoglobin and Haematocrit levels

Timeline

Start
2017-08-01
Primary completion
2018-11-30
Completion
2019-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferfer Unknown — Oral